Janus faces of amyloid proteins in neuroinflammation.
Amyloid forming molecules are generally considered harmful. In Alzheimer's Disease two amyloid molecules Aβ A4 and tau vie for consideration as the main pathogenic culprit. But molecules obey the laws of chemistry and defy the way we categorize them as humans with our well-known proclivities to bias in our reasoning. We have been exploring the brains of multiple sclerosis patients to identify molecules that are associated with protection from inflammation and degeneration. In 2001 we noted that aB crystallin (cryab) was the most abundant transcript found in MS lesions, but not in healthy brains. Cryab can reverse paralysis and attenuate inflammation in several models of inflammation including experimental autoimmune encephalomyelitis (EAE), and various models of ischemia. Cryab is an amyloid forming molecule. We have identified a core structure common to many amyloids including amyloid protein Aβ A4, tau, amylin, prion protein, serum amyloid protein P, and cryab. The core hexapeptide structure is highly immune suppressive and can reverse paralysis in EAE when administered systemically. Administration of this amyloid forming hexapeptide quickly lowers inflammatory cytokines in plasma like IL-6 and IL-2. The hexapeptide bind a set of proinflammatory mediators in plasma, including acute phase reactants and complement components. The beneficial properties of amyloid forming hexapeptides provide a potential new therapeutic direction. These experiments indicate that amyloid forming molecules have Janus faces, providing unexpected benefit for neuroinflammatory conditions.
Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA, Steinman@stanford.edu.
Lawrence
L
Steinman
Jonathan B
JB
Rothbard
Michael P
MP
Kurnellas
D000544:Alzheimer Disease / Q000276:immunology*; D058227:Amyloidogenic Proteins / Q000276:immunology*; D000818:Animals; D001921:Brain / Q000276:immunology*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology*; D006801:Humans; D015850:Interleukin-6 / Q000276:immunology; D051379:Mice; D009103:Multiple Sclerosis / Q000276:immunology*; D020078:Neurogenic Inflammation / Q000276:immunology
D058227:Amyloidogenic Proteins; D015850:Interleukin-6